TrakCel and McKesson will be hosting the 3rd Cell Gene Therapy Network meeting taking place around the CAR-TCR Summit 2019 in Boston, US.
Following on from the success of the previous meeting in Miami, the event will provide an intimate and interactive networking forum for professionals in the cell gene therapy industry in a relaxed setting.
The event will include a guest keynote from Dave McLean of ETS (Emerging Therapy Solutions) which will discuss the reimbursement landscape of advanced therapies – a key challenge and potential barrier to the overall success of the cell and gene therapy sector. It will also have a short presentation that details TrakCel and McKesson’s shared vision for the advancement in personalized medicine delivery and patient care.
Guest keynote from Emerging Therapy Solutions
The event is a short, 4-minute walk from the Boston Seaport Hotel and will be providing canapes and drinks upon arrival.
Due to the interactive nature of the event, places will be limited and will be offered on a first come, first served basis. Booking early is recommended.
Agenda
5:30pm: Arrival Networking, drinks and canapes
5:45pm: Introduction to CGTN (McKesson & TrakCel) “This is our Why”
6:00pm: Guest Speaker: Emerging Therapy Solutions (Dave J. McLean, Chief Executive Officer)
6:20pm: Q and A session
6:30pm: Prize draw
6:40pm: Networking, drinks and canapes
7:30pm: Event ends
The event is a short, 4-minute walk from the Boston Seaport Hotel and will be providing canapes and drinks upon arrival.
Due to the interactive nature of the event, places will be limited and will be offered on a first come, first served basis. It is recommended that you book early to avoid disappointment.